South Wales pharma company expands into Japan
Biotec Services International has joined forces with Osaka-based CoreMed Corporation to help promote its clinical services in the Japanese biopharmaceutical industry.
Biotec Services International has joined forces with Osaka-based CoreMed Corporation to help promote its clinical services in the Japanese biopharmaceutical industry.
The Bridgend, South Wales-based firm is a clinical trials supply company specialising in clinical services for Phase I to IV trials through to commercial supplies. It is already supporting more than 100 clinical trials and has the capacity and facilities to store products over a wide range of temperatures, down to -80ºC.
Biotec’s business development director, Fiona Withey, said: ‘CoreMed will help Biotec find companies that require the services we offer and in return we will help CoreMed locate non-Japanese pharmaceutical companies who require contract regulatory and strategic development services.’
Biotec said it had a very successful 2008, following aggressive marketing activity in North America and Israel. The company’s turnover was in excess of £3m, with a 140% increase in export sales.
Having established itself in the US market by securing a number of new contracts with clients on the west coast, the company feels it is also important to develop business with clients across the globe.
Last year Biotec moved into its custom-built £1.5m facility in Bridgend and changed its name to Biotec Services International to reflect its continued growth in the US, Canada, Israel and Japan.
Biotec Services International
T +44 1656 750550
F +44 1656 750569